Rockwell Medical, Inc.

NASDAQ:RMTI

0.82 (USD) • At close July 2, 2025
Bedrijfsnaam Rockwell Medical, Inc.
Symbool RMTI
Munteenheid USD
Prijs 0.818
Beurswaarde 27,961,740
Dividendpercentage 0%
52-weken bereik 0.78 - 5.15
Industrie Drug Manufacturers—Specialty & Generic
Sector Healthcare
CEO Dr. Mark Strobeck Ph.D.
Website https://www.rockwellmed.com

An error occurred while fetching data.

Over Rockwell Medical, Inc.

Rockwell Medical, Inc., together with its subsidiaries, operates as a biopharmaceutical company that targets end-stage renal disease and chronic kidney disease with therapies and products for the treatment of iron deficiency and hemodialysis in the United States and internationally. The company offers Triferic Dialysate and Triferic AVNU, an iron therapy

Vergelijkbare Aandelen

Unicycive Therapeutics, Inc. logo

Unicycive Therapeutics, Inc.

UNCY

4.64 USD

Star Equity Holdings, Inc. logo

Star Equity Holdings, Inc.

STRR

1.95 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)